🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Osama Mohamad

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-2972-657X

Also affiliated with American University of Beirut Medical Center, American University of Beirut

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

(2023)10.1158/1078-0432.c.6531062
Top 100%
0DataRank
Top 100%0 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Papers

Driven by 5 papers — median percentile 0. Top paper: “SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial”.

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.10.137
N/A
0DataRank · unranked
26 citations

Samer Salamekh, Neil Desai, Aurélie Garant, Michael R. Folkert, Daniel N. Costa +15 more

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2083
N/A
0DataRank · unranked
24 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Prostate cancer risk in African American men evaluated via digital histopathology multi-modal deep learning models developed on NRG Oncology phase III clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.108
N/A
0DataRank · unranked
6 citations

Jingbin Zhang, Andre Esteva, Osama Mohamad, Douwe van der Wal, Jeffry Simko +15 more

Data from Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

(2023)10.1158/1078-0432.c.6531062
Top 100%
0DataRank
Top 100%0 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging–assisted radiosurgery (MARS)

Brachytherapy(2025)10.1016/j.brachy.2025.09.005
N/A
0DataRank · unranked
0 citations

Kelsey L. Corrigan, Surendra Prajapati, Rajat J. Kudchadker, Gohar Manzar, Elaine Cha +6 more